Erik Emerson
Chief Commercial Officer, Adhera Therapeutics, Inc.
Companies
- Apimeds Pharmaceuticals US, Inc.Board member May 8, 2025 to now1
- Apimeds Pharmaceuticals US, Inc.Chief executive officer May 8, 2025 to now1
- Adhera Therapeutics, Inc.Board member Jul 12, 2018 to Jul 12, 20182
- Adhera Therapeutics, Inc.Chief Commercial Officer Jun 27, 2017 to Jul 12, 20183
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Apimeds Pharmaceuticals US, Inc. APUS750,000 shares4$2.6M at $3.48May 16, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- May 16, 2025Granted 750,000 shares of Apimeds Pharmaceuticals US, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4